Email
Get the latest from The Australian Business
To view this email as a web page, go here.

Good morning,

Wall Street has rocketed on US President Donald Trump's 90-day pause on tariffs for some nations, but Australia’s economy faces a material hit from the escalating US-China trade war as a mooted tariff on pharmaceuticals unsettles investors in biotech giant CSL.

Meanwhile, a cyber attack into Australia’s biggest industry superannuation funds has descended into a farce with confusion among law enforcement agencies about who is leading an investigation into the raid, technology editor Jared Lynch reports.

And the alleged vulgarity at the heart of former Tabcorp boss Adam Rytenskild’s contested exit from the bookmaker has been described in court documents as trading a sexual act for regulatory suitability. Read what the court documents revealed.

Vesna Poljak
Business editor
The markets


Making news this morning
1
Trump orders 90-day tariff pause, but hits China with 125pc levy
Donald Trump has retreated on tariffs for US trading partners that didn’t retaliate, reducing their levies to a ‘baseline’ rate of 10 per cent, but China faces even higher levies after hitting back with retaliatory tariffs of 84 per cent.
2
Gold Road forced to retract mine claims after complaint to ASX
Takeover target Gold Road has been forced to retract details about the underground potential of the jointly run Gruyere mine after a complaint was made to the ASX.
3
Coalition gas plan labelled counter-productive by industry
The gas industry has cast doubt over the federal Coalition’s energy policy modelling but Opposition leader Peter Dutton insists his plan will lower energy bills.
Editor's picks
MARGIN CALL
Climate 200 juiced up on Kremlin
Independent Climate 200-backed MPs reckon they’re the best friend the Jewish community has in Canberra but don’t mind their benefactor appearing to be part of the Kremlin cheer squad.
By YONI BASHAN, NICK EVANS
Commentary
Tariff fight pitches Middle America against China’s factories
By ERIC JOHNSTON
Associate Editor
There’s a new pain threshold being calculated by global markets, and it’s getting to the point where the winner really will take all.
China’s now a much fitter opponent for Trump tariffs bout
By GLENDA KORPORAAL
Senior writer
Donald Trump has picked a trade fight with an economic giant in China that has changed considerably since he challenged it during his first term in office.
DataRoom
Crunch time nearing for Healthscope
Brookfield’s next move for the embattled hospital group could be to place the business into voluntary administration.
Mineral Resources considered raising, Wodgina sale, say sources
The Chris Ellison-backed group is said to have been quietly assessing options to reduce its $5bn net debt balance.
Domain deal hopes falling with its share price
As Domain’s share price lost further ground on Wednesday, the market seems to be betting on suitor CoStar walking away.

image